Commentary by Robert Leonard PharmD, Pharmacy Resident New York Harbor Healthcare System
On November 20, 2007 the FDA announced mounting evidence linking varenicline (Chantix®) therapy for smoking cessation with suicidal ideation and erratic and aggressive behavior. …
Commentary by Neal Steigbigel MD, Professor of Medicine (Infectious Diseases/Immunology)
Methicillin resistant Staphylococcus aureus (MRSA) was a hot topic at this year’s IDSA meeting. The CA (community-acquired)-MRSA strains are spreading rapidly in …
Commentary by Shrujal Baxi MD, Ethics Section Editor, and Joseph Lowy MD, Medical Director, Palliative Care Service at NYU Hospital
Mrs. Pleasant is an 85 year old woman brought into the ER by her son …
Commentary by Urania Rappo, PGY-2
This week’s Medicine Grand Rounds guest lecturer was Dr. Robert Finberg, currently Chair of the Department of Medicine at the University of Massachusetts Medical School. He earned his MD …
Commentary by Jonathan Willner MD, PGY-2
This week’s Medicine Grand Rounds speaker was Lisa Carey, MD, Associate Professor in Hematology/Oncology at the University of North Carolina and Medical Director of the UNC …
Commentary by Jatin Roper MD PGY-3 and Christine Ren MD Associate Professor, Department of Surgery
Bariatric procedures to treat obesity involve the restriction of the gastric reservoir, bypass of part of the gastrointestinal tract, …
Commentary by Helen Kourlas PharmD, Pharmacology Section Editor
On October 16th the FDA announced the approval of raltegravir (Isentress®) for the treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents. The …
Welcome to our Grand Rounds Series. Each week, we plan to post a summary of the week’s Medicine Grand Rounds lecture. The summaries are reviewed and approved by the grand rounds speaker …